Anti-tumor necrosis factors (TNFs) are outdated—It's time to move on: Session three summary

Réme Mountifield

doi:10.1111/jgh.15455

Anti-tumor necrosis factors (TNFs) are outdated—It's time to move on: Session three summary

Réme Mountifield

College of Medicine and Public Health

Research output: Contribution to journal › Conference article › peer-review

Abstract

For this lively and informative session, the affirmative argument was taken by Assistant Professor Parambir Dulai, and the negative by Dr Nick Kennedy. A summary of the key points from each presenter’s arguments are presented.

Original language	English
Pages (from-to)	25-26
Number of pages	2
Journal	Journal of Gastroenterology and Hepatology (Australia)
Volume	36
Issue number	S1
DOIs	https://doi.org/10.1111/jgh.15455
Publication status	Published - Apr 2021
Event	IBD 2020: Right therapy, right patient, right time#Choosing wisely: Proceedings of the Takeda IBD Symposium - Virtual Duration: 5 Sept 2020 → 9 Sept 2020

Bibliographical note

Funding Information:
Funded through an unrestricted educational grant from Takeda Pharmaceuticals Pty Ltd.

Keywords

anti-tumor necrosis factors
TNF
inflammatory bowel disease (IBD)

Access to Document

10.1111/jgh.15455Licence: In Copyright

Cite this

@article{72e278134c3942628749ee826b6cca04,

title = "Anti-tumor necrosis factors (TNFs) are outdated—It's time to move on: Session three summary",

abstract = "For this lively and informative session, the affirmative argument was taken by Assistant Professor Parambir Dulai, and the negative by Dr Nick Kennedy. A summary of the key points from each presenter{\textquoteright}s arguments are presented.",

keywords = "anti-tumor necrosis factors, TNF, inflammatory bowel disease (IBD)",

author = "R{\'e}me Mountifield",

note = "Funding Information: Funded through an unrestricted educational grant from Takeda Pharmaceuticals Pty Ltd.; IBD 2020: Right therapy, right patient, right time#Choosing wisely : Proceedings of the Takeda IBD Symposium ; Conference date: 05-09-2020 Through 09-09-2020",

year = "2021",

month = apr,

doi = "10.1111/jgh.15455",

language = "English",

volume = "36",

pages = "25--26",

journal = "Journal of Gastroenterology and Hepatology (Australia)",

issn = "0815-9319",

publisher = "John Wiley & Sons, Inc",

number = "S1",

}

TY - JOUR

T1 - Anti-tumor necrosis factors (TNFs) are outdated—It's time to move on

T2 - IBD 2020: Right therapy, right patient, right time#Choosing wisely

AU - Mountifield, Réme

N1 - Funding Information: Funded through an unrestricted educational grant from Takeda Pharmaceuticals Pty Ltd.

PY - 2021/4

Y1 - 2021/4

N2 - For this lively and informative session, the affirmative argument was taken by Assistant Professor Parambir Dulai, and the negative by Dr Nick Kennedy. A summary of the key points from each presenter’s arguments are presented.

AB - For this lively and informative session, the affirmative argument was taken by Assistant Professor Parambir Dulai, and the negative by Dr Nick Kennedy. A summary of the key points from each presenter’s arguments are presented.

KW - anti-tumor necrosis factors

KW - TNF

KW - inflammatory bowel disease (IBD)

UR - http://www.scopus.com/inward/record.url?scp=85103575603&partnerID=8YFLogxK

U2 - 10.1111/jgh.15455

DO - 10.1111/jgh.15455

M3 - Conference article

C2 - 33817852

AN - SCOPUS:85103575603

SN - 0815-9319

VL - 36

SP - 25

EP - 26

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

IS - S1

Y2 - 5 September 2020 through 9 September 2020

ER -

Anti-tumor necrosis factors (TNFs) are outdated—It's time to move on: Session three summary

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this